Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative dexamethasone for postoperative pain after periacetabular osteotomy
2019-000402-30Phase 2Completed
- Sponsor
- Viktoria Lindberg-Larsen
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dexamethasone in hip dysplasia (DDH) (3 arms), sponsored by Viktoria Lindberg-Larsen. Primary endpoint: Cumulated postoperative morphine consumption at 48 hours. Started Mar 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
hip dysplasia (DDH)
Beyond the preview
Go deeper on 2019-000402-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000402-30.